0001181431-14-004179.txt : 20140128 0001181431-14-004179.hdr.sgml : 20140128 20140128173936 ACCESSION NUMBER: 0001181431-14-004179 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140127 FILED AS OF DATE: 20140128 DATE AS OF CHANGE: 20140128 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDIVATION, INC. CENTRAL INDEX KEY: 0001011835 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133863260 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 525 MARKET STREET STREET 2: 36TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 BUSINESS PHONE: 415-543-3470 MAIL ADDRESS: STREET 1: 525 MARKET STREET STREET 2: 36TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 FORMER COMPANY: FORMER CONFORMED NAME: ORION ACQUISITION CORP II DATE OF NAME CHANGE: 19960408 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hung David CENTRAL INDEX KEY: 0001310880 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32836 FILM NUMBER: 14554100 MAIL ADDRESS: STREET 1: 501 SECOND STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94107 4 1 rrd400763.xml 1/27/2014 -- SALE PURSUANT TO 10B-5PLAN X0306 4 2014-01-27 0 0001011835 MEDIVATION, INC. MDVN 0001310880 Hung David C/O MEDIVATION, INC. 525 MARKET ST., 36TH FLOOR SAN FRANCISCO CA 94105 1 1 0 0 President and CEO Common Stock 2014-01-27 4 M 0 150000 5.88 A 1100204 D Common Stock 2014-01-27 4 S 0 11000 71.77 D 1089204 D Common Stock 2014-01-27 4 S 0 61823 72.99 D 1027381 D Common Stock 2014-01-27 4 S 0 62577 73.72 D 964804 D Common Stock 2014-01-27 4 S 0 1700 74.75 D 963104 D Common Stock 2014-01-27 4 S 0 9900 76.15 D 953204 D Common Stock 2014-01-27 4 S 0 3000 76.43 D 950204 D Common Stock 86060 I By trust Employee Stock Option (right to buy) 5.88 2014-01-27 4 M 0 300000 0 D 2016-10-31 Common Stock 300000 50000 D Shares sold pursuant to a 10b5-1 Plan. The shares were sold at prices ranging from $71.27 to $72.24. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $72.31 to $73.305. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $73.32 to $74.30. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $74.34 to $75.34. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $75.385 to $76.38. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $76.40 to $76.46. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Fully vested. /s/ Patrick Machado, Attorney-in-fact 2014-01-28